XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Composition of Certain Financial Statement Captions (Tables)
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Composition of Certain Financial Statement Captions
(In thousands)September 30,
2022
December 31,
2021
Accounts receivable, net:
Accounts receivable$129,576 $261,476 
Less: allowance for credit losses(6,388)(1,839)
$123,188 $259,637 
Inventories, net:
Consumable supplies$30,211 $39,447 
Finished products37,188 44,107 
Work in-process2,580 1,615 
Raw materials6,417 6,112 
Less: inventory reserve(4,967)(4,779)
$71,429 $86,502 
Other current assets and prepaid expenses:
Taxes recoverable$5,161 $5,598 
Prepaid expenses9,785 10,641 
Prepaid insurance7,331 4,383 
Other receivables9,899 353 
Other6,340 6,195 
$38,516 $27,170 
Intangible assets, net:
Customer relationships$309,758 $314,823 
Technologies812,118 246,101 
Trade names49,713 49,770 
Covenants not to compete12,897 12,920 
Licenses5,969 5,766 
Product registrations6,119 6,995 
Other5,483 6,128 
Less: accumulated amortization(366,921)(320,820)
$835,136 $321,683 
Accrued expenses:
Inventory received but not invoiced$13,545 $40,446 
Commitments and contingencies1,647 27,819 
Employee benefits45,124 45,939 
Contract liabilities257 258 
Clinical trials4,073 4,867 
Contingent consideration— 487 
Finance leases short-term2,580 2,257 
Professional fees1,630 2,121 
Other43,159 69,299 
$112,015 $193,493 
(In thousands)September 30,
2022
December 31,
2021
Other long-term liabilities:
Contingent consideration$1,671 $2,350 
Mortgages and other debts payable8,970 2,224 
Finance leases long-term4,350 2,924 
Contract liabilities136 208 
Other7,425 7,356 
$22,552 $15,062 
Changes in Goodwill
The following table summarizes the changes in Goodwill by reporting unit during the nine months ended September 30, 2022.
2022
(In thousands)Gross goodwill at January 1Cumulative impairment at January 1Acquisitions and dispositionsForeign exchange and otherBalance at September 30
Pharmaceuticals
CURNA$4,827 $(4,827)$— $— $— 
Rayaldee86,554 — — (11,509)75,045 
FineTech11,698 (11,698)— — — 
ModeX— — 65,865 — 65,865 
OPKO Biologics139,784 — — — 139,784 
OPKO Chile3,760 — — (440)3,320 
OPKO Health Europe7,478 — — (1,018)6,460 
OPKO Mexico100 (100)— — — 
Transition Therapeutics3,421 (3,421)— — — 
Diagnostics
BioReference434,809 — (151,784)— 283,025 
OPKO Diagnostics17,977 (17,977)— — — 
$710,408 $(38,023)$(85,919)$(12,966)$573,499